K840863

Substantially Equivalent

SERATEST RF LATEX DETERMINATION

Applicant: Seragen Diagnostics, Inc.
Product code: DHR
Advisory panel: Immunology
Date received: 1984-02-24
Decision date: 1984-04-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.